Because less is known about drugs in early development, quality systems are even more important at this stage.
Aug 1, 2008
By:
Laura Bush
|
GMPs in Phase 1 is more important now than ever before.
Just as antibody production is hitting maturity, areas like personalized medicine are presenting new difficulties.
Jul 1, 2008
By:
Laura Bush
|
Pushing frontiers in a maturing biotechnology industry.
Increased agency funding, whether through budget allocations or user fees, will not prevent another heparin crisis.
Jun 1, 2008
By:
Laura Bush
|
A stronger FDA will benefit both the industry and the public. And it now looks like we are starting down a path to build up that strength.
Now is a good time for companies to know their suppliers well.
Apr 1, 2008
By:
Laura Bush
|
Now is a good time for companies to know their suppliers well.
Mar 1, 2008
By:
Laura Bush
|
The cause of the heparin crisis is still unknown. We do know, however, that the FDA is severely underfunded.
In our increasingly global industry; foreign manufacturing inspections are more important than ever.
Feb 1, 2008
By:
Laura Bush
|
In our increasingly global industry; foreign manufacturing inspections are more important than ever.
Jan 1, 2008
By:
Laura Bush
|
The number one source of job satisfaction? A sense of accomplishment from a job well done.
Dec 1, 2007
By:
Laura Bush
|
Many companies acknowledged that Western regulatory standards are tougher than those in China.
Nov 1, 2007
By:
Laura Bush
|
The challenge is not in coming up with a list of activities to discard, but in finding a feasible way to stop doing them.
